Novartis India Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 98.16 | 94.51 | 103.60 |
| Operating Expense | 60.31 | 59.97 | 67.42 |
| Net Profit | 27.62 | 29.30 | 25.45 |
| Net Profit Margin | 28.14 | 31.00 | 24.57 |
| Earning Per Share | 11.19 | 11.87 | 10.31 |
| EBIDTA | 37.85 | 33.79 | 36.11 |
| Effective Tax Rate | 25.36 | 11.12 | 27.00 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 98.16 |
| Operating Expense | 60.31 |
| Net Profit | 27.62 |
| Net Profit Margin | 28.14 |
| Earning Per Share | 11.19 |
| EBIDTA | 37.85 |
| Effective Tax Rate | 25.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 356.27 | 335.07 | 378.74 |
| Operating Expenses Annual | 264.85 | 269.81 | 313.66 |
| Operating Profit Annual | 133.38 | 126.94 | 123.19 |
| Interest Annual | 0.77 | 1.49 | 1.75 |
| Depreciation | 2.19 | 2.61 | 6.06 |
| Net Profit Annual | 100.90 | 85.19 | 103.36 |
| Tax Annual | 29.52 | 37.65 | 12.02 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 356.27 |
| Operating Expenses Annual | 264.85 |
| Operating Profit Annual | 133.38 |
| Interest Annual | 0.77 |
| Depreciation | 2.19 |
| Net Profit Annual | 100.90 |
| Tax Annual | 29.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 44.96 | 19.42 | 158.35 |
| Cash Flow from Operations | 74.57 | 113.40 | 44.80 |
| Cash Flow from Investing | -3.31 | 33.13 | -153.25 |
| Cash Flow from Financing | -64.15 | -120.99 | -30.48 |
| Cash Flow at the End | 52.07 | 44.96 | 19.42 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 44.96 |
| Cash Flow from Operations | 74.57 |
| Cash Flow from Investing | -3.31 |
| Cash Flow from Financing | -64.15 |
| Cash Flow at the End | 52.07 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 34.19 | 34.60 | 29.79 |
| PBIT Margin (%) | 33.63 | 33.89 | 28.33 |
| PBT Margin (%) | -10.05 | 11.14 | 12.14 |
| Net PROFIT Margin (%) | 25.87 | 23.22 | 25.00 |
| Return On Networth / Equity (%) | 13.19 | 11.21 | 14.09 |
| Return On Networth /Employed (%) | 16.64 | 15.57 | 14.88 |
| Return On Assets (%) | 12.67 | 10.68 | 13.25 |
| Total Debt / Equity (X) | 0.01 | 0.02 | 0.03 |
| Asset Turnover Ratio (%) | 0.49 | 0.46 | 0.53 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 34.19 |
| PBIT Margin (%) | 33.63 |
| PBT Margin (%) | -10.05 |
| Net PROFIT Margin (%) | 25.87 |
| Return On Networth / Equity (%) | 13.19 |
| Return On Networth /Employed (%) | 16.64 |
| Return On Assets (%) | 12.67 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 4.54 | 6.94 | 19.25 |
| Total Current Assets Annual | 745.82 | 699.26 | 677.33 |
| Non Current Assets Annual | 201.99 | 225.67 | 305.61 |
| Total Shareholders Funds Annual | 784.96 | 744.82 | 775.66 |
| Total Assets Annual | 947.81 | 924.93 | 982.94 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 4.54 |
| Total Current Assets Annual | 745.82 |
| Non Current Assets Annual | 201.99 |
| Total Shareholders Funds Annual | 784.96 |
| Total Assets Annual | 947.81 |
No Data Availabe
